{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T04:21:02Z","timestamp":1744258862988,"version":"3.40.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T00:00:00Z","timestamp":1682121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T00:00:00Z","timestamp":1682121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s00210-023-02461-1","type":"journal-article","created":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T06:02:07Z","timestamp":1682143327000},"page":"2427-2447","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Analysis of differential gene immune infiltration and clinical characteristics of skin cutaneous melanoma based on systems biology and drug repositioning methods to identify drug candidates for skin cutaneous melanoma"],"prefix":"10.1007","volume":"396","author":[{"given":"Shengyong","family":"Long","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,22]]},"reference":[{"key":"2461_CR1","doi-asserted-by":"publisher","first-page":"17990","DOI":"10.1073\/pnas.1901323116","volume":"116","author":"S AbuHammad","year":"2019","unstructured":"AbuHammad S, Cullinane C, Martin C et al (2019) Regulation of PRMT5-MDM4 axis is critical in the response to CDK4\/6 inhibitors in melanoma. Proc Natl Acad Sci U S A 116:17990\u201318000. https:\/\/doi.org\/10.1073\/pnas.1901323116","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2461_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1101\/sqb.2013.78.019877","volume":"78","author":"S Akira","year":"2013","unstructured":"Akira S (2013) Regnase-1, a ribonuclease involved in the regulation of immune responses. Cold Spring Harb Symp Quant Biol 78:51\u201360. https:\/\/doi.org\/10.1101\/sqb.2013.78.019877","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"2461_CR3","doi-asserted-by":"publisher","unstructured":"Baroudjian B, Pag\u00e8s C, Lebb\u00e9 C (2016) Melanoma, from diagnosis to treatment. Rev Infirm:16\u201318 https:\/\/doi.org\/10.1016\/j.revinf.2015.12.022","DOI":"10.1016\/j.revinf.2015.12.022"},{"key":"2461_CR4","doi-asserted-by":"publisher","unstructured":"Binnewies M, Roberts EW, Kersten K et al. (2018) Understanding the tumor immune microenvironment (TIME) for effective therapy 24:541\u2013550. https:\/\/doi.org\/10.1038\/s41591-018-0014-x","DOI":"10.1038\/s41591-018-0014-x"},{"key":"2461_CR5","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/s41419-020-03097-2","volume":"11","author":"I Das","year":"2020","unstructured":"Das I, Chen H, Maddalo G et al (2020) Inhibiting Insulin and mTOR Signaling by Afatinib and Crizotinib Combination Fosters Broad Cytotoxic Effects in Cutaneous Malignant Melanoma. Cell Death Dis 11:882. https:\/\/doi.org\/10.1038\/s41419-020-03097-2","journal-title":"Cell Death Dis"},{"key":"2461_CR6","doi-asserted-by":"publisher","unstructured":"Dong C, Dang D, Zhao X et al. (2021) Integrative characterization of the role of IL27 in melanoma using bioinformatics analysis 1 12:713001. https:\/\/doi.org\/10.3389\/fimmu.2021.713001","DOI":"10.3389\/fimmu.2021.713001"},{"key":"2461_CR7","doi-asserted-by":"publisher","first-page":"126476","DOI":"10.1016\/j.jtemb.2020.126476","volume":"60","author":"A Ecker","year":"2020","unstructured":"Ecker A, Barbosa NV, Ardisson-Araujo D (2020) Accessing the transcriptional status of selenoproteins in skin cancer-derived cell lines. J Trace Elem Med Biol 60:126476. https:\/\/doi.org\/10.1016\/j.jtemb.2020.126476","journal-title":"J Trace Elem Med Biol"},{"key":"2461_CR8","doi-asserted-by":"publisher","unstructured":"Fiscon G, Conte F, Farina L et al. (2022) A comparison of network-based methods for drug repurposing along with an application to human complex diseases. Int J Mol Sci 23. https:\/\/doi.org\/10.3390\/ijms23073703","DOI":"10.3390\/ijms23073703"},{"key":"2461_CR9","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1002\/ijc.31199","volume":"142","author":"SJ Gallagher","year":"2018","unstructured":"Gallagher SJ, Gunatilake D, Beaumont KA et al (2018) HDAC inhibitors restore BRAF-inhibitor sensitivity by altering PI3K and survival signalling in a subset of melanoma. Int J Cancer 142:1926\u20131937. https:\/\/doi.org\/10.1002\/ijc.31199","journal-title":"Int J Cancer"},{"key":"2461_CR10","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s10637-014-0066-9","volume":"32","author":"NB Haas","year":"2014","unstructured":"Haas NB, Quirt I, Hotte S et al (2014) Phase II trial of vorinostat in advanced melanoma. Invest New Drugs 32:526\u2013534. https:\/\/doi.org\/10.1007\/s10637-014-0066-9","journal-title":"Invest New Drugs"},{"key":"2461_CR11","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.7150\/thno.30890","volume":"9","author":"Y Han","year":"2019","unstructured":"Han Y, Gu Z, Wu J et al (2019) Repurposing Ponatinib as a Potent Agent against KIT Mutant Melanomas. Theranostics 9:1952\u20131964. https:\/\/doi.org\/10.7150\/thno.30890","journal-title":"Theranostics"},{"key":"2461_CR12","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of Cancer: the next Generation. Cell 144:646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"key":"2461_CR13","doi-asserted-by":"publisher","first-page":"108","DOI":"10.5114\/wo.2014.41390","volume":"19","author":"EA Hoffman","year":"2015","unstructured":"Hoffman EA, Gizelska K, Mirowski M et al (2015) Arsenic trioxide downregulates cancer procoagulant activity in MCF-7 and WM-115 cell lines in vitro. Contemp Oncol (Pozn) 19:108\u2013112. https:\/\/doi.org\/10.5114\/wo.2014.41390","journal-title":"Contemp Oncol (Pozn)"},{"key":"2461_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/CMR.0b013e328304974c","volume":"19","author":"J Homsi","year":"2009","unstructured":"Homsi J, Cubitt CL, Zhang S et al (2009) Src activation in melanoma and Src inhibitors as therapeutic agents in melanoma. Melanoma Res 19:167\u2013175. https:\/\/doi.org\/10.1097\/CMR.0b013e328304974c","journal-title":"Melanoma Res"},{"key":"2461_CR15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12935-020-01271-2","volume":"20","author":"B Huang","year":"2020","unstructured":"Huang B, Han W, Sheng ZF et al (2020) Identification of immune-related biomarkers associated with tumorigenesis and prognosis in cutaneous melanoma patients. Cancer Cell Int 20:195. https:\/\/doi.org\/10.1186\/s12935-020-01271-2","journal-title":"Cancer Cell Int"},{"key":"2461_CR16","doi-asserted-by":"publisher","unstructured":"Kalaora S, Nagler A, Wargo JA (2022) Mechanisms of immune activation and regulation: lessons from melanoma. https:\/\/doi.org\/10.1038\/s41568-022-00442-9","DOI":"10.1038\/s41568-022-00442-9"},{"key":"2461_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s10020-019-0098-x","volume":"25","author":"A Khosravi","year":"2019","unstructured":"Khosravi A, Jayaram B, Goliaei B et al (2019) Active repurposing of drug candidates for melanoma based on GWAS, PheWAS and a wide range of omics data. Mol Med 25:30. https:\/\/doi.org\/10.1186\/s10020-019-0098-x","journal-title":"Mol Med"},{"key":"2461_CR18","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.bbrc.2016.09.061","volume":"479","author":"Y Kou","year":"2016","unstructured":"Kou Y, Li L, Li H et al (2016) Berberine suppressed epithelial mesenchymal transition through cross-talk regulation of PI3K\/AKT and RAR\u03b1\/RAR\u03b2 in melanoma cells. Biochem Biophys Res Commun 479:290\u2013296. https:\/\/doi.org\/10.1016\/j.bbrc.2016.09.061","journal-title":"Biochem Biophys Res Commun"},{"key":"2461_CR19","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13059-016-1028-7","volume":"17","author":"B Li","year":"2016","unstructured":"Li B, Severson E, Pignon J-C et al (2016) Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. Genome Biol 17:174. https:\/\/doi.org\/10.1186\/s13059-016-1028-7","journal-title":"Genome Biol"},{"key":"2461_CR20","doi-asserted-by":"publisher","unstructured":"Li T, Fu J, Zeng Z et al (2020) TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res 48(W1):W509\u2013W514. https:\/\/doi.org\/10.1093\/nar\/gkaa407","DOI":"10.1093\/nar\/gkaa407"},{"key":"2461_CR21","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3892\/or.2018.6221","volume":"39","author":"M Liu","year":"2018","unstructured":"Liu M, Liu H, Chen J (2018b) Mechanisms of the CDK4\/6 inhibitor palbociclib (PD 0332991) and its future application in cancer treatment (Review). Oncol Rep 39:901\u2013911. https:\/\/doi.org\/10.3892\/or.2018.6221","journal-title":"Oncol Rep"},{"key":"2461_CR22","doi-asserted-by":"publisher","first-page":"18515","DOI":"10.1038\/s41598-020-75598-1","volume":"10","author":"Y Liu","year":"2020","unstructured":"Liu Y, Hao Y, Li Y et al (2020) Salinomycin induces autophagic cell death in salinomycin-sensitive melanoma cells through inhibition of autophagic flux. Sci Rep 10:18515. https:\/\/doi.org\/10.1038\/s41598-020-75598-1","journal-title":"Sci Rep"},{"key":"2461_CR23","doi-asserted-by":"publisher","unstructured":"Liu JF, Lai KC, Peng SF et al. (2018a) Berberine Inhibits human melanoma A375.S2 cell migration and invasion via affecting the FAK, uPA, and NF-\u03baB signaling pathways and inhibits PLX4032 resistant A375.S2 cell migration in vitro. Molecules 23. https:\/\/doi.org\/10.3390\/molecules23082019","DOI":"10.3390\/molecules23082019"},{"key":"2461_CR24","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","volume":"173","author":"TM Malta","year":"2018","unstructured":"Malta TM, Sokolov A, Gentles AJ et al (2018) Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell 173:338-354.e315. https:\/\/doi.org\/10.1016\/j.cell.2018.03.034","journal-title":"Cell"},{"key":"2461_CR25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s13555-014-0051-4","volume":"4","author":"M Mansuy","year":"2014","unstructured":"Mansuy M, Nikkels-Tassoudji N, Arrese JE et al (2014) Recurrent in situ melanoma successfully treated with ingenol mebutate. Dermatol Ther (Heidelb) 4:131\u2013135. https:\/\/doi.org\/10.1007\/s13555-014-0051-4","journal-title":"Dermatol Ther (Heidelb)"},{"key":"2461_CR26","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/icb.2013.11","volume":"91","author":"R Miao","year":"2013","unstructured":"Miao R, Huang S, Zhou Z et al (2013) Targeted disruption of MCPIP1\/Zc3h12a results in fatal inflammatory disease. Immunol Cell Biol 91:368\u2013376. https:\/\/doi.org\/10.1038\/icb.2013.11","journal-title":"Immunol Cell Biol"},{"key":"2461_CR27","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1056\/NEJMoa1914609","volume":"382","author":"RK Murthy","year":"2020","unstructured":"Murthy RK, Loi S, Okines A et al (2020) Tucatinib, trastuzumab, and capecitabine for HER2-positive metastatic breast cancer. N Engl J Med 382:597\u2013609. https:\/\/doi.org\/10.1056\/NEJMoa1914609","journal-title":"N Engl J Med"},{"key":"2461_CR28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/vco.12312","volume":"16","author":"S Noguchi","year":"2018","unstructured":"Noguchi S, Shibutani S, Fukushima K et al (2018) Bosutinib, an SRC inhibitor, induces caspase-independent cell death associated with permeabilization of lysosomal membranes in melanoma cells. Vet Comp Oncol 16:69\u201376. https:\/\/doi.org\/10.1111\/vco.12312","journal-title":"Vet Comp Oncol"},{"key":"2461_CR29","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.3892\/ijo.2018.4452","volume":"53","author":"S Ohkubo","year":"2018","unstructured":"Ohkubo S, Dalla Via L, Grancara S et al (2018) The antioxidant, aged garlic extract, exerts cytotoxic effects on wild-type and multidrug-resistant human cancer cells by altering mitochondrial permeability. Int J Oncol 53:1257\u20131268. https:\/\/doi.org\/10.3892\/ijo.2018.4452","journal-title":"Int J Oncol"},{"key":"2461_CR30","doi-asserted-by":"publisher","unstructured":"Pandey PR, Young KH, Kumar D (2022) RNA-mediated immunotherapy regulating tumor immune microenvironment: next wave of cancer therapeutics 21:58. https:\/\/doi.org\/10.1186\/s12943-022-01528-6","DOI":"10.1186\/s12943-022-01528-6"},{"key":"2461_CR31","doi-asserted-by":"publisher","first-page":"4626","DOI":"10.1093\/bioinformatics\/btaa563","volume":"36","author":"Y Peng","year":"2020","unstructured":"Peng Y, Yuan M, Xin J et al (2020) Screening novel drug candidates for Alzheimer\u2019s disease by an integrated network and transcriptome analysis. Bioinformatics 36:4626\u20134632. https:\/\/doi.org\/10.1093\/bioinformatics\/btaa563","journal-title":"Bioinformatics"},{"key":"2461_CR32","doi-asserted-by":"publisher","first-page":"7559","DOI":"10.1158\/0008-5472.Can-07-0309","volume":"67","author":"C Perrotta","year":"2007","unstructured":"Perrotta C, Bizzozero L, Falcone S et al (2007) Nitric oxide boosts chemoimmunotherapy via inhibition of acid sphingomyelinase in a mouse model of melanoma. Cancer Res 67:7559\u20137564. https:\/\/doi.org\/10.1158\/0008-5472.Can-07-0309","journal-title":"Cancer Res"},{"key":"2461_CR33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom S, Iorio F, Eyers PA et al (2019) Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov 18:41\u201358. https:\/\/doi.org\/10.1038\/nrd.2018.168","journal-title":"Nat Rev Drug Discov"},{"key":"2461_CR34","first-page":"249","volume":"22","author":"L Qing","year":"2017","unstructured":"Qing L, Zhang L, Ji L et al (2017) Prognosis and influencing factors of 74 cases of cutaneous melanoma. J Clin Oncol 22:249\u2013254","journal-title":"J Clin Oncol"},{"key":"2461_CR35","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s10517-020-04916-4","volume":"169","author":"M Ren","year":"2020","unstructured":"Ren M, Yang L, Li D et al (2020) Cell cycle regulation by berberine in human melanoma A375 cells. Bull Exp Biol Med 169:491\u2013496. https:\/\/doi.org\/10.1007\/s10517-020-04916-4","journal-title":"Bull Exp Biol Med"},{"key":"2461_CR36","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2174\/1871520614666140902153840","volume":"15","author":"S Roy","year":"2015","unstructured":"Roy S, Narang BK, Rastogi SK et al (2015) A novel multiple tyrosine-kinase targeted agent to explore the future perspectives of anti-angiogenic therapy for the treatment of multiple solid tumors: cabozantinib. Anticancer Agents Med Chem 15:37\u201347. https:\/\/doi.org\/10.2174\/1871520614666140902153840","journal-title":"Anticancer Agents Med Chem"},{"key":"2461_CR37","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","volume":"118","author":"AD Singh","year":"2011","unstructured":"Singh AD, Turell ME, Topham AK (2011) Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology 118:1881\u20131885. https:\/\/doi.org\/10.1016\/j.ophtha.2011.01.040","journal-title":"Ophthalmology"},{"key":"2461_CR38","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fgene.2019.00294","volume":"10","author":"AR Sonawane","year":"2019","unstructured":"Sonawane AR, Weiss ST, Glass K et al (2019) Network medicine in the age of biomedical big data. Front Genet 10:294. https:\/\/doi.org\/10.3389\/fgene.2019.00294","journal-title":"Front Genet"},{"key":"2461_CR39","doi-asserted-by":"publisher","first-page":"D1420","DOI":"10.1093\/nar\/gkaa1020","volume":"49","author":"D Sun","year":"2021","unstructured":"Sun D, Wang J, Han Y et al (2021) TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment. Nucleic Acids Res 49:D1420-d1430. https:\/\/doi.org\/10.1093\/nar\/gkaa1020","journal-title":"Nucleic Acids Res"},{"key":"2461_CR40","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.cell.2018.04.012","volume":"173","author":"L Wang","year":"2018","unstructured":"Wang L, Leitede Oliveira R, Huijberts S et al (2018) An acquired vulnerability of drug-resistant melanoma with therapeutic potential. Cell 173:1413-1425.e1414. https:\/\/doi.org\/10.1016\/j.cell.2018.04.012","journal-title":"Cell"},{"key":"2461_CR41","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1111\/exd.13349","volume":"26","author":"YR Woo","year":"2017","unstructured":"Woo YR, Lim JH, Jeong SW et al (2017) Analysis of apoptosis-associated molecules erythroid differentiation regulator 1, bcl-2 and p53 in actinic keratosis after treatment with ingenol mebutate. Exp Dermatol 26:1012\u20131017. https:\/\/doi.org\/10.1111\/exd.13349","journal-title":"Exp Dermatol"},{"key":"2461_CR42","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00280-014-2501-1","volume":"74","author":"C Xia","year":"2014","unstructured":"Xia C, Leon-Ferre R, Laux D et al (2014) Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide). Cancer Chemother Pharmacol 74:691\u2013697. https:\/\/doi.org\/10.1007\/s00280-014-2501-1","journal-title":"Cancer Chemother Pharmacol"},{"key":"2461_CR43","doi-asserted-by":"crossref","unstructured":"Xu C, Parsons PG (1999)\u00a0Cell cycle delay, mitochondrial stress and uptake of hydrophobic cations induced by sunscreens in cultured human cells. Photochem Photobiol 69:611\u2013616","DOI":"10.1111\/j.1751-1097.1999.tb03336.x"},{"key":"2461_CR44","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1158\/0008-5472.Can-15-2931","volume":"76","author":"A Yoshida","year":"2016","unstructured":"Yoshida A, Lee EK, Diehl JA (2016) Induction of therapeutic senescence in vemurafenib-resistant melanoma by extended inhibition of CDK4\/6. Cancer Res 76:2990\u20133002. https:\/\/doi.org\/10.1158\/0008-5472.Can-15-2931","journal-title":"Cancer Res"},{"key":"2461_CR45","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y et al (2012) clusterProfiler: an R package for comparing biological themes among gene clusters. Omics 16:284\u2013287. https:\/\/doi.org\/10.1089\/omi.2011.0118","journal-title":"Omics"},{"key":"2461_CR46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13073-022-01050-w","volume":"14","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Wang ZX, Chen YX et al (2022) Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response. Genome Med 14:45. https:\/\/doi.org\/10.1186\/s13073-022-01050-w","journal-title":"Genome Med"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02461-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-023-02461-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02461-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T16:07:23Z","timestamp":1744214843000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-023-02461-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,22]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["2461"],"URL":"https:\/\/doi.org\/10.1007\/s00210-023-02461-1","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"type":"print","value":"0028-1298"},{"type":"electronic","value":"1432-1912"}],"subject":[],"published":{"date-parts":[[2023,4,22]]},"assertion":[{"value":"6 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Second Affiliated Hospital of Lanzhou University.Patients\/participants provided their written informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}